The contribution of multicenter trials to stroke prevention and treatment.
Barnett
H J
HJ
John P. Robarts Research Institute, London, Canada.
D000925:Anticoagulants / Q000627:therapeutic use; D002545:Brain Ischemia / Q000628:therapy; D002339:Carotid Arteries / Q000601:surgery; D002548:Cerebral Revascularization; D002561:Cerebrovascular Disorders / Q000517:prevention & control* / Q000628:therapy; D004691:Endarterectomy; D005069:Evaluation Studies as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D015337:Multicenter Studies as Topic; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015424:Reperfusion
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors